In the present study, we established ALS-specific human iPSCs from two patients with a point mutation in the FUS gene and isogenic iPSCs with FUS H517D homozygous mutations derived from healthy 409B2 iPSCs using the TALEN genome editing system. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.